Home Tags Bioconjugation technology

Tag: bioconjugation technology

Synaffix Expands Licensing Agreement with Mersana

ADC Review | Editorial Team
The Netherlands-based Synaffix, a biotechnology company focusing on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), confirmed the expansions of...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X